ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SUN Surgical Innovations Group Plc

0.50
0.10 (25.00%)
18 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Surgical Innovations Group Plc LSE:SUN London Ordinary Share GB0004016704 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.10 25.00% 0.50 0.40 0.60 0.50 0.50 0.50 17,945,588 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Surgical,med Instr,apparatus 11.34M 264k 0.0003 16.67 4.66M
Surgical Innovations Group Plc is listed in the Surgical,med Instr,apparatus sector of the London Stock Exchange with ticker SUN. The last closing price for Surgical Innovations was 0.40p. Over the last year, Surgical Innovations shares have traded in a share price range of 0.40p to 2.25p.

Surgical Innovations currently has 932,816,000 shares in issue. The market capitalisation of Surgical Innovations is £4.66 million. Surgical Innovations has a price to earnings ratio (PE ratio) of 16.67.

Surgical Innovations Share Discussion Threads

Showing 11901 to 11925 of 11925 messages
Chat Pages: 477  476  475  474  473  472  471  470  469  468  467  466  Older
DateSubjectAuthorDiscuss
18/4/2024
21:54
Good to see some of the old Board members stepping down. Let's home the new Board members can add something extra to the company.
john148
18/4/2024
16:10
@justiceforthemany thanks
mandate
18/4/2024
15:22
I expect to see net cash around £1M by year end and a positive operating profit.
Group revenue +8% year on year should equal an extra £1M.
Costs hopefully stable to down year on year.
Energy costs down, inflation down.
The company stated they will try to grow revenue substantially via Japan, India and South America (new). Time will tell.

(APH = Alliance Pharma)

justiceforthemany
18/4/2024
15:14
@Blackhorse23 Who or what is APH?
mandate
18/4/2024
12:52
Profit moved to APH
blackhorse23
18/4/2024
12:04
Significant growth opportunities in India and Japan.
Revenue to double within 5 years.
Historically this share has averaged 2p.

justiceforthemany
18/4/2024
10:45
The outlook is positive. Revenue is up year on year.
Costs and wages down significantly.
EBITDA is +ve in 2024.
New contracts signed worth 3x the current market cap; revenue is also 3x the whole market cap.
New products released.
Do you really think the whole company is worth £3.9M?
A rich individual could buy it today.

justiceforthemany
18/4/2024
10:24
Ebitda is under 3% and where were the profits gone? How to finance capex?
1choip
18/4/2024
09:51
"Based on what?"

Cash.

glavey
18/4/2024
09:25
Today was the best time to announce one.
justiceforthemany
18/4/2024
09:24
Based on what?
justiceforthemany
18/4/2024
08:32
I have a feeling they'll need to raise funds soon.
jmf69
18/4/2024
08:02
Sell off was unwarranted.
£0.5M reduction in costs/wages this year.
New contracts signed.

justiceforthemany
17/4/2024
19:52
PIs could easily buy the whole company down here.
justiceforthemany
16/4/2024
22:40
Let's face it at 0.4p and a £4M market cap the market is saying this company is pretty much bust.
justiceforthemany
13/4/2024
17:44
Let us imagine for a moment you are correct and CMR perform 36,000 cases in the coming year. How much do CMR charge for a set of SUN products? Say £50? So SUN would sell them to CMR at around £25.00 - maybe more, maybe less but this order of magnitude.
36,000 x £24 is £900,000.

Is under £1m growth from what you say is a key driver going to change the world for SUN?

barrenwuffet2
11/4/2024
04:03
CMR Surgical sales will IMO now start to help Surgical Innovations begin its recovery

Remember, March 23rd 2022


CMR Surgical & Surgical Innovations develop new surgical hybrid port access system

~ Surgical Innovations’ new YelloPort Elite™ 5mm, with reusable trocar and canula, reduces cost and waste generated when compared with traditional fully single use Port Access Systems

~ Developed with CMR Surgical, the port access system is the latest addition to Surgical Innovation’s Resposable® range of products and is designed specifically for the Versius® Surgical Robotic System

CMR Surgical announced Versius robots have performed 1,000 operations Nov 25th 2020

2 and one half years later

CMR Surgical announced Versius robots have performed 10,000 operations Apr 20th 2023

11 months later

CMR Surgical announced Versius robots have performed 20,000 operations Mar 21st 2024



On january 4th 2024 CMR Surgical announced that 17,000 operations had been performed with some interesting stats

~ After a record quarter, CMR closes the year with a Versius global install base more than 50% higher than 2022

~ Over 17,000 surgical procedures completed using Versius, representing a procedural growth rate of over 60% in 2023, compared with 2022, with an increasing number of complex surgeries being undertaken with Versius

~ Continued expansion into new markets in Europe, Asia, Middle East, Africa, and Latin America




----- It is worth also remembering that for the majority of Versius robotic operations , 4 robotic arms are normally used meaning 4 new YelloPort Elite™ 5mm devices being used with one of those also used for viewing purposes with an optical disposable trocar ---- which at long last Surgical Innovations are now providing

There is every chance in the next 12 months Versius can hit at least 36,000 operations performed or in other words carry out 16,000 operations from Mar 21st 2024 to Mar 21st 2025

New seals are needed as supplied by surgical Innovations for every operation/Versius arm that uses a new YelloPort Elite™ 5mm trocar

So not only are SUN providing the new YelloPort Elite™ 5mm optical trocars to CMR Surgical , they also keep selling 3 sets of seals and a plastic optical trocar for many of these operations



It would be nice to think that SUN are in and have been for some time , in the process of designing another instrument that CMR Surgical will also use

dyor

buywell3
10/4/2024
22:52
can someone resucitate this flatlining heap?
cashflo
03/4/2024
12:05
Contact investor relations.
Ask why the results are still not out yet.

justiceforthemany
02/4/2024
19:29
More dumping again today just the end really what a heap
cashflo
02/4/2024
13:53
Z1co - not sure previous posts are deserving of this bad grace. The fact is the company has consistently lost its shareholders money over the long, medium and short term. It’s a difficult space for a small medical device manufacturer. Compliance costs are huge, UK prices are pretty much fixed by the NHS so no upside, and global markets are not as fixated on Net Zero as our NHS. One way out would be by acquiring something interesting but the value of the business makes this an expensive way to grow. Not a lot to get excited about in the medium term here.
barrenwuffet2
29/3/2024
00:25
Loads of dumpinmg today not a single buyu. Is there any point anymore ? what a load. Who's runnning this company
cashflo
28/3/2024
15:09
I wouldn't buy even if reporting figures are good. Any good news is likely to be greeted by a small tick up in the S/P followed by a gradual decline after. And yes, I still hold a few thousand of this stock.
john148
28/3/2024
12:50
PUGUGLY

Get a life you pathetic person.

Is that what you do every day , it appears you don't own any stock.

Another sad loser.

btw

I no longer own due to stop loss but i'm still watching from the side lines and depending what they say regarding their current trading so far in 2024 will buy again.

z1co
28/3/2024
12:20
Massive dump appears to be in progress - Now 0.4351 to sell. Chances of doing a BYOT?
pugugly
Chat Pages: 477  476  475  474  473  472  471  470  469  468  467  466  Older

Your Recent History

Delayed Upgrade Clock